We are analyzing https://link.springer.com/article/10.1007/bf00047609.

Title:
Stem cells and the development of mammary cancers in experimental rats and in humans | Cancer and Metastasis Reviews
Description:
Evidence based on immunocytochemical staining and ultrastructure suggests that morphological gradations between epithelial and myoepithelial cells, and possibly between epithelial cells and alveolar-like cells occur in terminal ductal structures of rat and human mammary glands. The benign carcinogen-induced rat and benign human mammary tumors can contain epithelial, myoepithelial-like and alveolar-like cells, whereas the malignant counterparts mainly contain only epithelial-like cells. Clonal epithelial cell lines from normal rat mammary glands, benign tumors, and SV40-transformed human mammary glands can differentiate to either myoepithelial-like or alveolar-like cells. In those of the rat, the differentiation processes occur in steps: intermediate cells along the myoepithelial-like pathway resemble intermediates in terminal ductal structures in vivo, and can also generate certain well-differentiated mesenchymal elements of the original tumours. Differentiation of the benign rat cells to alveolar-like cells with mammatrophic hormones and retinoids in vitro leads to a reduction in their tumor-forming ability in vivo. Cell lines from malignant rat mammary tumors of increasing metastatic potential and from human ductal carcinomas largely fail to yield myoepithelial-like or alveolar-like cells and are relatively slow-growing. Growth of the rat mammary epithelial cells in culture is stimulated by a pituitary-derived mammatrophic growth factor (PMGF), prostaglandin E2, and α-transforming growth factor; the response of the malignant cell lines to PMGF is reduced. It is suggested that stem cells exist in the rat and human glands that are capable of differentiating to the other major cell types of the mammary parenchyma, and that during the carcinogenic process they generate genetically unstable cells which lose their ability to differentiate and attempt to maximise their intrinsically slow growth rate.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Science
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don't see any clear sign of profit-making.

Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Link.springer.com might have a hidden revenue stream, but it's not something we can detect.

Keywords {🔍}

google, scholar, mammary, cancer, cell, cells, rat, breast, rudland, human, epithelial, res, natl, growth, differentiation, gland, inst, stem, normal, tumor, warburton, monaghan, lines, ormerod, vitro, culture, line, tumors, myoepithelial, york, membrane, glands, smith, mouse, development, malignant, pathol, cultured, biol, metastasis, article, proc, hughes, gusterson, benign, myoepitheliallike, hormones, study, sci, antigen,

Topics {✒️}

1-methyl-1-nitrosourea-induced mammary carcinogenesis month download article/chapter wild-type ret receptor microtubule-disrupting drugs increase carcinogen-induced hyperplastic nodules stem cell line carcinogen-induced tumor epithelium mcf-12a cell phenotype benign carcinogen-induced rat cultured stem cells dmba-induced breast tumors α-transforming growth factor mammary epithelia-prostaglandin e2 stem cell characteristics differentiated mesenchymal elements stem cells exist benign stem cells march 1987 volume 6 mesenchymal tissues participating rat mammary tumor full article pdf rat mammary epithelial cultured mammary epithelial clifton kh dimethyl sulfoxide-induced differentiation mesenchymal induction demonstrated malignant cell lines human tumor cells established cell line pathway resemble intermediates cultured mammary cells cell lines derived sv40 gene expression check access instant access tumor cell populations rat mammary glands aneuploid mammary epithelial rat mammary gland malignant mammary tumors epithelial cell types syngeneic cell lines stromal cell lines privacy choices/manage cookies rat mammary preadipocytes mammary cancer induced epithelial-specific cytodifferentiation mammary carcinomas induced human mammary glands mammary gland carcinogen

Questions {❓}

Ferguson DJP: Ultrastructural characterisation of the proliferative (stem?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Stem cells and the development of mammary cancers in experimental rats and in humans
         description:Evidence based on immunocytochemical staining and ultrastructure suggests that morphological gradations between epithelial and myoepithelial cells, and possibly between epithelial cells and alveolar-like cells occur in terminal ductal structures of rat and human mammary glands. The benign carcinogen-induced rat and benign human mammary tumors can contain epithelial, myoepithelial-like and alveolar-like cells, whereas the malignant counterparts mainly contain only epithelial-like cells. Clonal epithelial cell lines from normal rat mammary glands, benign tumors, and SV40-transformed human mammary glands can differentiate to either myoepithelial-like or alveolar-like cells. In those of the rat, the differentiation processes occur in steps: intermediate cells along the myoepithelial-like pathway resemble intermediates in terminal ductal structures in vivo, and can also generate certain well-differentiated mesenchymal elements of the original tumours. Differentiation of the benign rat cells to alveolar-like cells with mammatrophic hormones and retinoids in vitro leads to a reduction in their tumor-forming ability in vivo. Cell lines from malignant rat mammary tumors of increasing metastatic potential and from human ductal carcinomas largely fail to yield myoepithelial-like or alveolar-like cells and are relatively slow-growing. Growth of the rat mammary epithelial cells in culture is stimulated by a pituitary-derived mammatrophic growth factor (PMGF), prostaglandin E2, and α-transforming growth factor; the response of the malignant cell lines to PMGF is reduced. It is suggested that stem cells exist in the rat and human glands that are capable of differentiating to the other major cell types of the mammary parenchyma, and that during the carcinogenic process they generate genetically unstable cells which lose their ability to differentiate and attempt to maximise their intrinsically slow growth rate.
         datePublished:
         dateModified:
         pageStart:55
         pageEnd:83
         sameAs:https://doi.org/10.1007/BF00047609
         keywords:
            rat and human mammary glands
            normal and benign
            stem cells and differentiation
            malignant cells
            growth factors
            genetic instability
            Cancer Research
            Oncology
            Biomedicine
            general
         image:
         isPartOf:
            name:Cancer and Metastasis Reviews
            issn:
               1573-7233
               0167-7659
            volumeNumber:6
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Kluwer Academic Publishers
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Philip S. Rudland
               affiliation:
                     name:Liverpool University
                     address:
                        name:Cancer and Polio Research Fund Laboratories, Biochemistry Department, Liverpool University, Liverpool, UK
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Stem cells and the development of mammary cancers in experimental rats and in humans
      description:Evidence based on immunocytochemical staining and ultrastructure suggests that morphological gradations between epithelial and myoepithelial cells, and possibly between epithelial cells and alveolar-like cells occur in terminal ductal structures of rat and human mammary glands. The benign carcinogen-induced rat and benign human mammary tumors can contain epithelial, myoepithelial-like and alveolar-like cells, whereas the malignant counterparts mainly contain only epithelial-like cells. Clonal epithelial cell lines from normal rat mammary glands, benign tumors, and SV40-transformed human mammary glands can differentiate to either myoepithelial-like or alveolar-like cells. In those of the rat, the differentiation processes occur in steps: intermediate cells along the myoepithelial-like pathway resemble intermediates in terminal ductal structures in vivo, and can also generate certain well-differentiated mesenchymal elements of the original tumours. Differentiation of the benign rat cells to alveolar-like cells with mammatrophic hormones and retinoids in vitro leads to a reduction in their tumor-forming ability in vivo. Cell lines from malignant rat mammary tumors of increasing metastatic potential and from human ductal carcinomas largely fail to yield myoepithelial-like or alveolar-like cells and are relatively slow-growing. Growth of the rat mammary epithelial cells in culture is stimulated by a pituitary-derived mammatrophic growth factor (PMGF), prostaglandin E2, and α-transforming growth factor; the response of the malignant cell lines to PMGF is reduced. It is suggested that stem cells exist in the rat and human glands that are capable of differentiating to the other major cell types of the mammary parenchyma, and that during the carcinogenic process they generate genetically unstable cells which lose their ability to differentiate and attempt to maximise their intrinsically slow growth rate.
      datePublished:
      dateModified:
      pageStart:55
      pageEnd:83
      sameAs:https://doi.org/10.1007/BF00047609
      keywords:
         rat and human mammary glands
         normal and benign
         stem cells and differentiation
         malignant cells
         growth factors
         genetic instability
         Cancer Research
         Oncology
         Biomedicine
         general
      image:
      isPartOf:
         name:Cancer and Metastasis Reviews
         issn:
            1573-7233
            0167-7659
         volumeNumber:6
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Kluwer Academic Publishers
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Philip S. Rudland
            affiliation:
                  name:Liverpool University
                  address:
                     name:Cancer and Polio Research Fund Laboratories, Biochemistry Department, Liverpool University, Liverpool, UK
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Cancer and Metastasis Reviews
      issn:
         1573-7233
         0167-7659
      volumeNumber:6
Organization:
      name:Kluwer Academic Publishers
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Liverpool University
      address:
         name:Cancer and Polio Research Fund Laboratories, Biochemistry Department, Liverpool University, Liverpool, UK
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Philip S. Rudland
      affiliation:
            name:Liverpool University
            address:
               name:Cancer and Polio Research Fund Laboratories, Biochemistry Department, Liverpool University, Liverpool, UK
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Cancer and Polio Research Fund Laboratories, Biochemistry Department, Liverpool University, Liverpool, UK
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(223)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.43s.

LINK . SPRINGER . COM {}